|
Sr. No. |
Product |
Therapeutic Category |
Pharmacopoeia |
US DMF |
CEP |
JP DMF |
ROW |
|
1 |
Metformin HCl |
Anti-Diabetics |
USP/EP/BP/JP/IP |
a |
a |
a |
a |
|
2 |
Gliclazide |
Anti-Diabetics |
EP/BP/IP |
|
a |
|
a |
|
3 |
Folic Acid |
Vitamin |
USP/EP/BP/IP |
a |
|
a |
|
|
4 |
Alogliptin Benzoate |
Anti-Diabetics |
IH |
|
|
a |
|
|
5 |
Ambroxol HCl |
Mucolytics |
EP/BP/IP |
|
|
|
a |
|
6 |
Pregabalin |
Neuropathic Pain |
USP/EP/BP/JP/IP |
|
|
a |
|
|
7 |
Fenofibrate |
Lipid Modifying Agent |
USP/BP/IP |
|
|
|
a |
|
8 |
Rebamipide |
Anti-Ulcer |
IH/JP |
Q4 2023 - 24 |
|||
|
9 |
Dapagliflozin |
Anti-Diabetics |
IH |
Q4 2023 - 24 |
|||
|
10 |
Docusate Sodium 85 |
Laxative |
USP |
Q4 2023 - 24 |
|||
|
11 |
Imeglimin HCl |
Anti-Diabetics |
IH |
Q4 2023 - 24 |
|||
|
12 |
Nitazoxanide |
Antiparasitic |
IH |
Q4 2023 - 24 |
|||
|
13 |
Sitagliptin Phosphate |
Anti-Diabetics |
USP/EP/BP/IP |
Q4 2023 - 24 |
|||